159 related articles for article (PubMed ID: 19555072)
1. A new approach in the preparation of dendrimer-based bifunctional diethylenetriaminepentaacetic acid MR contrast agent derivatives.
Nwe K; Xu H; Regino CA; Bernardo M; Ileva L; Riffle L; Wong KJ; Brechbiel MW
Bioconjug Chem; 2009 Jul; 20(7):1412-8. PubMed ID: 19555072
[TBL] [Abstract][Full Text] [Related]
2. Comparison of MRI properties between derivatized DTPA and DOTA gadolinium-dendrimer conjugates.
Nwe K; Bernardo M; Regino CA; Williams M; Brechbiel MW
Bioorg Med Chem; 2010 Aug; 18(16):5925-31. PubMed ID: 20663676
[TBL] [Abstract][Full Text] [Related]
3. Poly(amidoamine) dendrimer based MRI contrast agents exhibiting enhanced relaxivities derived via metal preligation techniques.
Nwe K; Bryant LH; Brechbiel MW
Bioconjug Chem; 2010 Jun; 21(6):1014-7. PubMed ID: 20462240
[TBL] [Abstract][Full Text] [Related]
4. Toward improved syntheses of dendrimer-based magnetic resonance imaging contrast agents: new bifunctional diethylenetriaminepentaacetic acid ligands and nonaqueous conjugation chemistry.
Xu H; Regino CA; Bernardo M; Koyama Y; Kobayashi H; Choyke PL; Brechbiel MW
J Med Chem; 2007 Jul; 50(14):3185-93. PubMed ID: 17552504
[TBL] [Abstract][Full Text] [Related]
5. Micro-MR angiography of normal and intratumoral vessels in mice using dedicated intravascular MR contrast agents with high generation of polyamidoamine dendrimer core: reference to pharmacokinetic properties of dendrimer-based MR contrast agents.
Kobayashi H; Kawamoto S; Saga T; Sato N; Hiraga A; Konishi J; Togashi K; Brechbiel MW
J Magn Reson Imaging; 2001 Dec; 14(6):705-13. PubMed ID: 11747027
[TBL] [Abstract][Full Text] [Related]
6. Dendrimer-based metal chelates: a new class of magnetic resonance imaging contrast agents.
Wiener EC; Brechbiel MW; Brothers H; Magin RL; Gansow OA; Tomalia DA; Lauterbur PC
Magn Reson Med; 1994 Jan; 31(1):1-8. PubMed ID: 8121264
[TBL] [Abstract][Full Text] [Related]
7. Phosphinic derivative of DTPA conjugated to a G5 PAMAM dendrimer: an 17O and 1H relaxation study of its Gd(III) complex.
Lebdusková P; Sour A; Helm L; Tóth E; Kotek J; Lukes I; Merbach AE
Dalton Trans; 2006 Jul; (28):3399-406. PubMed ID: 16832488
[TBL] [Abstract][Full Text] [Related]
8. Novel liver macromolecular MR contrast agent with a polypropylenimine diaminobutyl dendrimer core: comparison to the vascular MR contrast agent with the polyamidoamine dendrimer core.
Kobayashi H; Kawamoto S; Saga T; Sato N; Hiraga A; Ishimori T; Akita Y; Mamede MH; Konishi J; Togashi K; Brechbiel MW
Magn Reson Med; 2001 Oct; 46(4):795-802. PubMed ID: 11590657
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the in vivo biodistribution of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA and its conjugation with anti-Tac monoclonal antibody.
Kobayashi H; Wu C; Kim MK; Paik CH; Carrasquillo JA; Brechbiel MW
Bioconjug Chem; 1999; 10(1):103-11. PubMed ID: 9893971
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of gadolinium complexes based on PAMAM as MRI contrast agents.
Yan GP; Hu B; Liu ML; Li LY
J Pharm Pharmacol; 2005 Mar; 57(3):351-7. PubMed ID: 15807991
[TBL] [Abstract][Full Text] [Related]
11. Rotational dynamics account for pH-dependent relaxivities of PAMAM dendrimeric, Gd-based potential MRI contrast agents.
Laus S; Sour A; Ruloff R; Tóth E; Merbach AE
Chemistry; 2005 May; 11(10):3064-76. PubMed ID: 15776490
[TBL] [Abstract][Full Text] [Related]
12. Dysprosium-DOTA-PAMAM dendrimers as macromolecular T2 contrast agents. Preparation and relaxometry.
Bulte JW; Wu C; Brechbiel MW; Brooks RA; Vymazal J; Holla M; Frank JA
Invest Radiol; 1998 Nov; 33(11):841-5. PubMed ID: 9818319
[TBL] [Abstract][Full Text] [Related]
13. Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores.
Kobayashi H; Kawamoto S; Jo SK; Bryant HL; Brechbiel MW; Star RA
Bioconjug Chem; 2003; 14(2):388-94. PubMed ID: 12643749
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and relaxometric studies of a dendrimer-based pH-responsive MRI contrast agent.
Ali MM; Woods M; Caravan P; Opina AC; Spiller M; Fettinger JC; Sherry AD
Chemistry; 2008; 14(24):7250-8. PubMed ID: 18601236
[TBL] [Abstract][Full Text] [Related]
15. Preparation, characterization and in vivo assessment of Gd-albumin and Gd-dendrimer conjugates as intravascular contrast-enhancing agents for MRI.
Nwe K; Milenic D; Bryant LH; Regino CA; Brechbiel MW
J Inorg Biochem; 2011 May; 105(5):722-7. PubMed ID: 21463567
[TBL] [Abstract][Full Text] [Related]
16. PAMAM dendrimers conjugated with an uncharged gadolinium(III) chelate with a fast water exchange: the influence of chelate charge on rotational dynamics.
Polásek M; Hermann P; Peters JA; Geraldes CF; Lukes I
Bioconjug Chem; 2009 Nov; 20(11):2142-53. PubMed ID: 19883075
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of a new MRI contrast agent prepared from polypropyleneimine dendrimers, generation 2.
Wang SJ; Brechbiel M; Wiener EC
Invest Radiol; 2003 Oct; 38(10):662-8. PubMed ID: 14501494
[TBL] [Abstract][Full Text] [Related]
18. Dendrimer-based MRI contrast agents: the effects of PEGylation on relaxivity and pharmacokinetics.
Kojima C; Turkbey B; Ogawa M; Bernardo M; Regino CA; Bryant LH; Choyke PL; Kono K; Kobayashi H
Nanomedicine; 2011 Dec; 7(6):1001-8. PubMed ID: 21515406
[TBL] [Abstract][Full Text] [Related]
19. Positive effects of polyethylene glycol conjugation to generation-4 polyamidoamine dendrimers as macromolecular MR contrast agents.
Kobayashi H; Kawamoto S; Saga T; Sato N; Hiraga A; Ishimori T; Konishi J; Togashi K; Brechbiel MW
Magn Reson Med; 2001 Oct; 46(4):781-8. PubMed ID: 11590655
[TBL] [Abstract][Full Text] [Related]
20. 3D-micro-MR angiography of mice using macromolecular MR contrast agents with polyamidoamine dendrimer core with reference to their pharmacokinetic properties.
Kobayashi H; Sato N; Hiraga A; Saga T; Nakamoto Y; Ueda H; Konishi J; Togashi K; Brechbiel MW
Magn Reson Med; 2001 Mar; 45(3):454-60. PubMed ID: 11241704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
